Last reviewed · How we verify
sildenafil citrate and questionaires — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
sildenafil citrate and questionaires (sildenafil citrate and questionaires) — Memorial Sloan Kettering Cancer Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| sildenafil citrate and questionaires TARGET | sildenafil citrate and questionaires | Memorial Sloan Kettering Cancer Center | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- sildenafil citrate and questionaires CI watch — RSS
- sildenafil citrate and questionaires CI watch — Atom
- sildenafil citrate and questionaires CI watch — JSON
- sildenafil citrate and questionaires alone — RSS
Cite this brief
Drug Landscape (2026). sildenafil citrate and questionaires — Competitive Intelligence Brief. https://druglandscape.com/ci/sildenafil-citrate-and-questionaires. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab